Literature DB >> 33000322

Vasculitis patient journey: a scoping review of patient experiences with vasculitis.

Navjeet Gill1, Jan Willem Cohen Tervaert2, Elaine Yacyshyn3.   

Abstract

In order to understand the vasculitis journey from the patient's perspective, the existing literature was reviewed regarding patient perceptions of vasculitis' effect on four main domains of health: physical, psychological, social, and financial. A scoping review was performed using CINAHL, Embase, MEDLINE, PsychINFO, and other sources (smaller databases and grey literature). Inclusion criteria included all forms of primary vasculitis, adult patients (≥ 18 years old), and patient perspectives regarding at least one of the four identified health domains. Aggregates of patient experiences with vasculitis were categorized into one of the four health domains: physical, psychological, social, and financial. Nineteen qualitative studies from 2294 total non-duplicated articles were included. Generalized themes emerged for each of the four domains. In relation to physical health, patients were most affected by fatigue. Psychologically, patients were most affected by anxiety. Socially, patients experienced decreased social participation due to lifestyle changes associated with disease and social perceptions of vasculitis. Financially, vasculitis patients had decreased employment due to functional decline. Each of the four domains contributed to a decreased quality of life associated with vasculitis. Decreased quality of life in vasculitis is due to multiple factors across several health domains. Understanding the patient's journey allows physicians to understand patient goals and to better support them in their recovery. Patients may also have an improved understanding of their journey and the most relevant health domains affected.

Entities:  

Keywords:  Fatigue; Mental health; Patient experience; Perspective; Scoping review; Vasculitis

Mesh:

Year:  2020        PMID: 33000322     DOI: 10.1007/s10067-020-05398-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  The Longitudinal Course of Fatigue in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Authors:  Lucy O'Malley; Katie L Druce; Dimitrios Chanouzas; Matthew D Morgan; Rachel Jones; David R W Jayne; Neil Basu; Lorraine Harper
Journal:  J Rheumatol       Date:  2019-07-01       Impact factor: 4.666

2.  Epidemiology of the vasculitides.

Authors:  Richard A Watts; David G I Scott
Journal:  Semin Respir Crit Care Med       Date:  2004-10       Impact factor: 3.119

3.  [Current studies of energy expenditure and the quantitative and qualitative adequacy of nutrition of female textile workers].

Authors:  V I Smoliar; L V Sobakar'
Journal:  Gig Sanit       Date:  1989-02

4.  Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study.

Authors:  Marc Hilhorst; Benjamin Wilde; Pieter van Paassen; Bjorn Winkens; Peter van Breda Vriesman; Jan Willem Cohen Tervaert
Journal:  Nephrol Dial Transplant       Date:  2012-12-06       Impact factor: 5.992

5.  Loss of self: a fundamental form of suffering in the chronically ill.

Authors:  K Charmaz
Journal:  Sociol Health Illn       Date:  1983-07

Review 6.  Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes.

Authors:  Joanna C Robson; David Jayne; Peter A Merkel; Jill Dawson
Journal:  Patient Relat Outcome Meas       Date:  2019-02-08

7.  Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure.

Authors:  Joanna C Robson; Jill Dawson; Peter F Cronholm; Nataliya Milman; Katherine S Kellom; Susan Ashdown; Ebony Easley; John T Farrar; Don Gebhart; Georgia Lanier; Carol A McAlear; Jacqueline Peck; Raashid A Luqmani; Judy A Shea; Gunnar Tomasson; Peter A Merkel
Journal:  Patient Relat Outcome Meas       Date:  2018-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.